MTOR gene variants are associated with severe COVID-19 outcomes: A multicenter study.
Tosta BR, de Almeida IM, da Cruz Pena L, Dos Santos Silva H, Reis-Goes FS, Silva NN, Cruz JVA, Dos Anjos Silva M, de Araújo JF, Rodrigues JL, Oliveira G, Figueiredo RG, Vaz SN, Montaño-Castellón I, Santana D, de Lima Beltrão FE, Carneiro VL, Campos GS, Brites C, Fortuna V, Figueiredo CA, Trindade SC, Ramos HE, Costa RDS.
Tosta BR, et al. Among authors: oliveira g.
Int Immunopharmacol. 2023 Dec;125(Pt B):111155. doi: 10.1016/j.intimp.2023.111155. Epub 2023 Nov 9.
Int Immunopharmacol. 2023.
PMID: 37951192